Protection against Influenza Virus Infection of Mice Fed Bifidobacterium breve YIT4064
Author(s) -
Hisako Yasui,
Junko Kiyoshima,
T Hori,
Kan Shida
Publication year - 1999
Publication title -
clinical and diagnostic laboratory immunology
Language(s) - English
Resource type - Journals
eISSN - 1098-6588
pISSN - 1071-412X
DOI - 10.1128/cdli.6.2.186-192.1999
Subject(s) - virus , virology , bifidobacterium breve , immunization , antigen , antibody , oral administration , influenza a virus , medicine , microbiology and biotechnology , immunology , biology , bifidobacterium , bacteria , pharmacology , lactobacillus , genetics
Mice fedBifidobacterium breve YIT4064 and immunized orally with influenza virus were more strongly protected against influenza virus infection of the lower respiratory tract than ones immunized with influenza virus only. The number of mice with enhanced anti-influenza virus immunoglobulin G (IgG) in serum upon oral administration ofB. breve YIT4064 and oral immunization with influenza virus was significantly greater than that upon oral immunization with influenza virus only. These findings demonstrated that the oral administration ofB. breve YIT4064 increased anti-influenza virus IgG antibodies in serum and protected against influenza virus infection. The oral administration ofB. breve YIT4064 may enhance antigen-specific IgG against various pathogenic antigens taken orally and induce protection against various virus infections.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom